^
BIOMARKER:

CD8 overexpression

i
Other names: CD8, CD8A, cluster of differentiation 8, CD8a Molecule, T-Cell Surface Glycoprotein CD8 Alpha Chain, T-Lymphocyte Differentiation Antigen T8/Leu-2, CD8 Antigen, Alpha Polypeptide (P32), Leu2 T-Lymphocyte Antigen, OKT8 T-Cell Antigen, T-Cell Antigen Leu2, T Cell Co-Receptor, T8 T-Cell Antigen, CD8a Antigen
Entrez ID:
Related biomarkers:
CD8 overexpression
Bladder Cancer
atezolizumab
Sensitive: C3 – Early Trials
Eur Urol - 2 weeks - (New C3)
CD8 overexpression
Breast Cancer
paclitaxel + epirubicin
Sensitive: C3 – Early Trials
ESMO-BC 2022 - 3 weeks - (New C3)
CD8 overexpression
NSCLC
PF-06801591
Sensitive: C3 – Early Trials
CD8 overexpression
Melanoma
ipilimumab
Sensitive: C3 – Early Trials
CD8 overexpression
NSCLC
pembrolizumab
Sensitive: C3 – Early Trials